2 results
Approved WMOCompleted
Primary: to assess efficacy of weekly subcutaneous (SC) administration of Abatacept vs. placebo on disease activity assessed with ESSDAI at in patients with pSS. Secondary: to assess efficacy of Abatacept on clinical, functional, subjective, and…
Approved WMOCompleted
The primary objective for this study is to demonstrate that SC injections of abatacept are non-inferior to IV infusions of abatacept .